AIGH Capital Management LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
AIGH Capital Management LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q4 2021$3,317,000
-5.1%
612,0000.0%1.01%
+37.6%
Q3 2021$3,494,000
-1.7%
612,0000.0%0.74%
+14.8%
Q2 2021$3,556,000
+180.2%
612,000
+163.8%
0.64%
+139.7%
Q1 2021$1,269,000–232,000–0.27%–
 Download
Other shareholders

There were no reported owners of HTG MOLECULAR DIAGNOSTICS IN in Q3 2021.

NameSharesValueWeighting ↓
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders